DEVECİ, O. S. Et Al. 2015. A Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels after Spironolactone Therapy. Journal of Hypertension: Open Access , vol.4, no.1 .

DEVECİ, O. S., Celik, A. I., Ikikardes, F., Caglıyan, C. E., ÖZMEN, Ç., DENİZ, A., ... AKILLI, R.(2015). A Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels after Spironolactone Therapy. Journal of Hypertension: Open Access , vol.4, no.1.

DEVECİ, ONUR Et Al. "A Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels after Spironolactone Therapy," Journal of Hypertension: Open Access , vol.4, no.1, 2015

DEVECİ, ONUR S. Et Al. "A Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels after Spironolactone Therapy." Journal of Hypertension: Open Access , vol.4, no.1, 2015

DEVECİ, O. S. Et Al. (2015) . "A Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels after Spironolactone Therapy." Journal of Hypertension: Open Access , vol.4, no.1.

@article{article, author={ONUR SİNAN DEVECİ Et Al. }, title={A Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels after Spironolactone Therapy}, journal={Journal of Hypertension: Open Access}, year=2015}